Introduction
============

Inflammation in a respiratory system, such as that associated with pneumonia, pleurisy, and bronchitis, is a frequent and fatal disorder encountered in veterinary medicine. In general, use of steroidal and non-steroidal anti-inflammatory drugs has been a major recommended strategy for the treatment of inflammatory disease \[[@B23]\]. However, though they are effective at relieving inflammation, many reports have demonstrated that the chronic use of these drugs is associated with a significant risk of serious adverse events in gastrointestinal \[[@B27]\], renal \[[@B9]\], and cardiovascular \[[@B3]\] systems. Because of these complications, much attention has been focused on alternative medicine approaches to the treatment of inflammatory diseases \[[@B4]\].

Subcutaneous injection of diluted bee venom (dBV) into an acupoint (termed apipuncture) has been used clinically in traditional oriental medicine, which produces potent anti-inflammatory effects in chronic inflammation patients \[[@B32]\]. Bee venom (BV) is comprised of various water-soluble extracts including peptides, enzymes, and biologically active amines that can stimulate the peripheral nerves and subsequently activate neurons in the brain and spinal cord \[[@B16]\]. Several reports have demonstrated that stimulation of the ST-36 acupoint with dBV significantly activates neurons in the locus coeruleus (LC) \[[@B37]\]. Since LC is the center of the descending noradrenergic system, increased activity of the LC provokes remarkable anti-inflammatory effects through the production of adrenal catecholamine \[[@B15]\]. Nevertheless, the use of dBV apipuncture has been limited to musculoskeletal inflammatory diseases such as arthritis \[[@B10]\], and it has not been considered for use in a therapeutic strategy for the treatment of respiratory inflammatory diseases.

Intrapleural injection of carrageenan induces acute inflammation in the pleural cavity through extravasation of polymorphonuclear leukocytes and macrophages into the pleural space after production of various proinflammatory cytokines or reactive oxygen species \[[@B2][@B8]\]. Because of these characteristics of carrageenan-induced inflammation, carrageenan-induced pleurisy has been used as a preclinical animal model when studying the mechanisms involved in acute respiratory inflammatory disease or when screening the effects of anti-inflammatory drugs on the respiratory system \[[@B34]\]. On that basis, carrageenan-induced pleurisy is an appropriate animal model for evaluating the anti-inflammatory effects of dBV apipuncture on respiratory inflammatory diseases in veterinary medicine.

By using a carrageenan-induced pleurisy mouse model, the present study aimed to investigate whether (1) stimulation of a specific acupoint with dBV is associated with modulation of the respiratory inflammation; and (2) dBV apipuncture can be an effective alternative therapy in the treatment of respiratory inflammation.

Materials and Methods
=====================

Animal preparation
------------------

Male Balb/c mice weighing 23 to 25 g and purchased from HanLim Experimental Animal (Korea) were used for this experiment. The animals were housed under controlled conditions: 12 h light/dark cycle, standard temperature (24 ± 2℃), and 40% to 50% humidity. Food and water were provided freely throughout the investigation. All mice were acclimated for one week prior to the beginning of the experiments. The entire experimental procedure and all methods were reviewed and approved by the Seoul National University Animal Care and Use Committee (approval No. SNU-160602-11), following the National Institutes of Health guidelines \[[@B33]\] and were in compliance with the ethical guidelines for investigations of experimental pain in conscious animals \[[@B39]\]. Animals were randomly assigned to experimental groups and subsequent drug treatments and analyses were performed blindly.

Carrageenan-induced pleurisy
----------------------------

Carrageenan-induced pleurisy was performed according to the method described in a previous report but with slight modification \[[@B24]\]. Briefly, mice were anesthetized with 3% isoflurane in a mixture of N~2~O/O~2~ gas and submitted to a skin incision at the level of the left sixth intercostal space. Sterile phosphate buffer saline (PBS; vehicle, 200 µL) or PBS containing 2% of λ-carrageenan (Sigma, USA) was injected into the pleural cavity by using a 24-gauge flexible catheter. Twenty-four hours after carrageenan injection, the animals were sacrificed and the chest was carefully opened. The pleural cavity was rinsed with 1 mL of sterile PBS with heparin (20 IU/mL), and the pleural exudate collected by aspiration. Any exudate contaminated with blood was discarded, and the amount of exudate was calculated by subtracting the volume of injected PBS from the total volume of collected fluids. The exudate fluid was diluted with Turk\'s solution at a ratio of 1:20 and the total number of leukocytes were counted by using an optical microscope and a Neubauer counting chamber. Animals were randomly assigned to experimental groups, and subsequent drug treatment and analyses were performed blindly.

Apipuncture with diluted bee venom
----------------------------------

BV from *Apis mellifera* (Sigma) was diluted to a 0.8 or 0.08 mg/kg concentration in 20 µL of sterile PBS. The dosage of diluted BV (dBV) was selected based on previous reports from our laboratories which showed that a 0.8 mg/kg dose of dBV produced the maximum anti-inflammatory effect without any significant side effects, such as allergic reactions or nociceptive behaviors \[[@B11][@B18]\]. The dBV was administered subcutaneously into the left *Chize* acupoint (LU-5; BV-A) located at the depression lateral to the biceps brachii tendon, in the cubital fossa \[[@B36]\] or into an arbitrary non-acupoint located near the midline of the back (BV-NA). The *Chize* is one of the lung meridians that is anatomically well-defined in mouse and rat, does not affect other acupoints when dBV is injected \[[@B36]\] and is widely used in the treatment of pulmonary diseases \[[@B6]\]. The first dBV treatment was started 5 min before the carrageenan injection and a second dBV treatment was administered 12 h after the carrageenan injection.

Measurement of myeloperoxidase activity
---------------------------------------

Myeloperoxidase (MPO) activity, a hallmark of neutrophil and macrophage accumulation in the inflammatory process \[[@B7]\], in the pleural exudate was measured at 24 h post-carrageenan injection by using a commercial MPO activity assay kit (Thermo Fisher Scientific, USA). Fluorescence was quantified at excitation/emission wavelengths of 530/590 nm, and the MPO activity of each sample was expressed as relative fluorescence units (RFU) compared to that of a sham group.

Evaluation of proinflammatory cytokines
---------------------------------------

At 24 h after the carrageenan or vehicle solution injection, the levels of interleukin 1 beta (IL-1β) and tumor necrosis factor alpha (TNF-α) in pleural exudates were evaluated by using a colorimetric, commercial enzyme-linked immunosorbent assay kit (R&D Systems, USA) that included specific monoclonal antibodies for each cytokine. The levels of IL-1β and TNF-α are expressed in pg/mL.

Immunohistochemistry
--------------------

In order to clarify further the mechanisms associated with the anti-inflammatory effects of the dBV treatment of the LU-5 acupoint, Fos-immunohistochemistry was performed on the hypothalamic paraventricular nucleus (PVN), the brain structure that controls hypothalamic-pituitary-adrenal (HPA) axis reactivity \[[@B13]\]. Briefly, mice were deeply anesthetized 2 h after dBV injection and then perfused transcardially with calcium-free Tyrode\'s solution followed by a fixative containing 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). The brain was removed from each animal immediately after perfusion, post-fixed for 3 h, and then placed in 30% sucrose in PBS (pH 7.4) 48 h at 4℃. Serial transverse sections (40 µm) were obtained throughout the rostrocaudal extent of the PVN. After elimination of endogenous peroxidase activity with 0.3% hydrogen peroxide and preblocking with 3% normal horse serum in 0.3% Triton X-100 in PBS, the free-floating sections were incubated in rabbit anti-Fos antibody (1:5,000; Calbiochem, USA) overnight at room temperature. Subsequently, the sections were washed and then incubated in biotinylated goat anti-rabbit IgG (1:200; Vector, USA) and the sections were processed by using an avidin--biotin--peroxidase procedure. Finally, visualization was performed using 3, 3′-diaminobenzidine (Sigma) with 0.2% nickel chloride intensification.

Image analysis
--------------

Image analysis was conducted as described previously \[[@B29]\]. The PVN sections were examined under a brightfield microscope (Nikon, Japan). PVN sections (from Bregma −0.58 to −0.94 mm) from each animal were scanned with a high-definition camera (DS-Fi3; Nikon). Images were captured to a computer by using NIS element software (Nikon). The number of Fos-immunoreactive (ir) neurons in the PVN were counted bilaterally (both ipsilateral \[Ipsi\] and contralateral \[Contra\] to the site of the dBV injection) on each image with a computer-assisted image analysis system (MetaMorph; Universal Imaging, USA). To maintain a constant threshold for each image and to compensate for subtle immunostaining variability, we only counted images that were at least 70% darker than the average gray level of each image after background subtraction and shading correction. All Fos quantitation procedures described above were performed blindly with regard to the experimental condition of each animal.

Statistical analysis
--------------------

All experimental data are expressed as means ± SEM, and statistical analysis was performed by using Prism 5.0 software (GraphPad Software, USA). Significance of the differences in each experiment was determined by performing one-way ANOVA followed by the Newman-Keuls multiple comparison tests to establish the *p* value among the experimental groups. An unpaired two-tailed Student\'s *t*-test was used to analyze the effects of dBV apipuncture on Fos expression in PVN. Analysis results with *p* values less than 0.05 were considered statistically significant.

Results
=======

Effect of diluted bee venom on pleural exudate volume in carrageenan-induced pleurisy
-------------------------------------------------------------------------------------

To investigate the potential effect of dBV in carrageenan-induced pleurisy, we examined the volume of pleural exudate from vehicle- or carrageenan-injected animals. Injection of carrageenan into pleural cavity induced an acute inflammatory response characterized by the accumulation of fluid ([Fig. 1](#F1){ref-type="fig"}). Interestingly, carrageenan mice treated with 0.8 mg/kg dBV at the LU-5 acupoint (BV-A 0.8) showed a significant reduction in exudate volume compared to that of vehicle-treated carrageenan mice. However, treatment of 0.08 mg/kg dBV at the LU-5 acupoint (BV-A 0.08) or treatment of 0.8 mg/kg dBV on non-acupoint (BV-NA 0.8) did not induce significant changes compared to that of vehicle-treated carrageenan mouse ([Fig. 1](#F1){ref-type="fig"}).

Effect of diluted bee venom on leukocyte accumulation in the pleural cavity
---------------------------------------------------------------------------

Next, we evaluated the number of leukocyte cells, indicators of inflammation, in pleural exudate. Carrageenan-injected mice showed a significant increase in leukocyte accumulation in the pleural exudate ([Fig. 2](#F2){ref-type="fig"}). However, mice undergoing 0.8 mg/kg dBV treatment of the LU-5 acupoint (BV-A 0.8) showed a potent anti-inflammatory effect (as indicated by a marked reduction in the number of leukocyte cells) when compared with that of vehicle-treated carrageenan mice. Neither 0.08 mg/kg dBV treatment of the LU-5 acupoint (BV-A 0.08) nor 0.8 mg/kg dBV at the non-acupoint (BV-NA 0.8) produced a significant reduction of leukocyte accumulation ([Fig. 2](#F2){ref-type="fig"}).

Effect of diluted bee venom on myeloperoxidase activity
-------------------------------------------------------

To examine further the effect of dBV apipuncture in the carrageenan-induced leukocyte accumulation, we investigated the activity of MPO in the pleural exudate ([Fig. 3](#F3){ref-type="fig"}). Administration of 0.8 mg/kg dBV at the LU-5 acupoint (BV-A 0.8) significantly inhibited the carrageenan-induced upregulation of MPO activity compared to that of vehicle treatment. However, mice treated with 0.08 mg/kg dBV at the LU-5 acupoint (BV-A 0.08) or 0.8 mg/kg dBV at the non-acupoint (BV-NA 0.8) did not produce significant changes in MPO activity compared to that of the vehicle-treated carrageenan mice ([Fig. 3](#F3){ref-type="fig"}).

Effect of diluted bee venom on production of IL-1β and TNF-α
------------------------------------------------------------

A remarkable increase in IL-1β and TNF-α production were observed in the pleural exudate of carrageenan-injected mice ([Fig. 4](#F4){ref-type="fig"}). Although the increase of IL-1β production due to carrageenan treatment was significantly inhibited by administration of 0.8 mg/kg dBV at the LU-5 acupoint (BV-A 0.8) (panel A in [Fig. 4](#F4){ref-type="fig"}), the same level of dBV treatment did not affect the levels of TNF-α compared to that in vehicle-treated mice (panel B in [Fig. 4](#F4){ref-type="fig"}). No significant changes in IL-1β and TNF-α production were observed following treatment of 0.08 mg/kg dBV at the LU-5 acupoint (BV-A 0.08) or 0.08 mg/kg dBV at the non-acupoint (BV-NA 0.8) compared to that following vehicle treatment ([Fig. 4](#F4){ref-type="fig"}).

Changes in Fos expression in the hypothalamic paraventricular nucleus following diluted bee venom pretreatment
--------------------------------------------------------------------------------------------------------------

A separate set of Fos-immunohistochemistry-based experiments was performed to clarify whether 0.8 mg/kg dBV administered at the LU-5 acupoint (BV-A 0.8) was associated with activation of PVN neurons. Representative photomicrographs of PVN sections from the dBV-treated mice (panel B in [Fig. 5](#F5){ref-type="fig"}) demonstrate that the number of Fos-ir neurons was significantly increased only in the contralateral side of the PVN in the dBV-treated groups (BV-A 0.8) compared to that of PVN of the vehicle-treated groups (Veh-A) (panel A in [Fig. 5](#F5){ref-type="fig"}).

Discussion
==========

BV apipuncture has been used in oriental medical fields to treat arthritis and rheumatoid diseases and to reduce pain in some Asian countries. Recently Western countries, including the United States, have been using BV treatment as an alternative therapy for multiple sclerosis, arthritis, and chronic inflammation \[[@B19]\]. Nevertheless, BV therapy is still limited to the treatment of musculoskeletal inflammatory diseases, such as arthritis, or neurological diseases \[[@B17]\]. In the present study, we provide novel evidence that dBV treatment of the LU-5 lung meridian acupoint can be an effective approach to alleviating inflammatory responses in the respiratory system. Intrapleural injection of carrageenan evoked acute inflammatory reactions in the pleural cavity, including increases in pleural exudate volume, leukocyte accumulation, MPO activity, and the production of inflammatory cytokines. Interestingly, subcutaneous dBV stimulation into the LU-5 acupoint markedly inhibited the increase of these inflammatory indicators in the carrageenan-induced pleurisy mouse model.

Carrageenan-induced inflammation has been reported to be associated with a biphasic profile of inflammatory responses in which early (within 4 h) and late (after 24 h) phases of inflammation are clearly observed \[[@B31]\]. This distinct profile is caused by infiltration of leukocytes from different lineages; acute neutrophil migration in the early phase and gradual macrophage migration in the late phase \[[@B30]\]. Furthermore, the concentration of cytokine-induced neutrophil chemoattractant-1 (CINC-1) in carrageenan-injected tissue increases to a peak only during the early phase of inflammation and is significantly decreased in the late phase of inflammation \[[@B22]\]. The results in these previous reports support the suggestion that the increased pleural exudate volume and increased production of inflammatory cytokines observed in our current results (24 h post-carrageenan injection) were associated with the accumulation of macrophages.

Interestingly, the present results showed that 0.8 mg/kg dBV apipuncture significantly blocked the increases in carrageenan-induced inflammatory indicators including exudate volume, number of accumulated leukocytes, MPO activity, and IL-1β level compared to the levels in vehicle-treated carrageenan-injected mice. However, the level of TNF-α in the pleural exudate was not affected by dBV treatment. It was previously reported that the expression level of TNF-α significantly increases only during the early phase of carrageenan-induced inflammation, while the production of IL-1β gradually increases during the late phase of inflammation \[[@B22][@B26]\]. Furthermore, TNF-α has been reported to play a role in regulating the accumulation of macrophages, which are the major source of IL-1β \[[@B1]\]. Therefore, our results suggest that dBV acupoint treatment effectively alleviates the inflammatory responses in carrageenan-induced pleurisy through the suppression of macrophage accumulation and inhibition of IL-1β production in the late phase of inflammation.

BV is composed with various constituents that include the lower molecular weight polypeptides apamin (2 kDa), melittin (3 kDa), mast cell degranulating (MCD) peptide (3 kDa), minimine (6 kDa), and adolapin (11 kDa) as well as a number of higher molecular weight glycoproteins including the enzymes PLA~2~ (19 kDa), lysophospholipase (22 kDa), and hyaluronidase (38 kDa) \[[@B14]\]. Several studies have demonstrated that direct application of melittin on lipopolysaccharide (LPS)-activated microglia or macrophage cells produces significant anti-inflammatory effects through a nuclear factor-κB--induced JNK pathway \[[@B28]\]. Moreover, purified MCD peptide and adolapin were reported to have anti-inflammatory activity \[[@B32]\], suggesting potent anti-inflammatory effects can be induced by direct BV application. However, in the present study, we did not inject dBV directly into the inflamed area, instead, it was injected into a specific acupoint located on cubital fossa of the left forelimb. Moreover, the amount of MCD peptide and adolapin is reported to present in very small quantities (1--2%) in whole BV \[[@B18]\]. Therefore, it is reasonable to assume that the present anti-inflammatory effects of dBV injection were not produced by the direct anti-inflammatory actions of the BV constituents, rather, they were evoked by another action that occurred following BV stimulation of the LU-5 acupoint.

A number of studies have demonstrated that activation of peripheral afferent nerves by electrical or chemical stimulation can be an effective therapeutic method for improving the inflammatory diseases \[[@B12][@B21]\]. These reports show the importance of neurological pathways on modulation of inflammatory responses. In this regard, subcutaneous injection of dBV has been considered a possible technique of peripheral nerve stimulation that can modulate inflammatory responses \[[@B37]\]. Our laboratories previously demonstrated that a dBV injection into the ST-36 acupoint (*Zusanli*) significantly increased the activity of LC neurons in brain stem \[[@B37]\]. Because LC are nuclei containing the cell bodies of noradrenergic neurons \[[@B25]\], the activation of LC neurons facilitates the release of adrenal catecholamines into the bloodstream, which ultimately results in the significant reduction of peripheral inflammation via β-adrenergic receptors \[[@B15]\].

Stimulation of LU-5 has been reported as effective in the improvement of the symptoms and pulmonary functions of patients with respiratory disease by regulating the autonomic nervous system and promoting the release of endogenous peptides at the hypothalamic level \[[@B20]\]. On that basis, we have taken a step toward elucidating some of the mechanistic details underlying the anti-inflammatory effect of dBV stimulation of the LU-5 acupoint. The mice treated with 0.8 mg/kg dBV at LU-5 showed a significantly increased level of Fos-ir in the contralateral PVN neurons. This contralateral PVN activation pattern has been similarly observed in a previous study from our laboratories which demonstrated that subcutaneous dBV injection into the hind limb selectively activates the contralateral LC \[[@B38]\]. Because the PVN is a brain center that activates the HPA axis, it seems plausible that dBV-induced neuronal signaling from the LU-5 acupoint to the contralateral PVN may activate the synthesis and release of adrenal glucocorticoid, a potent anti-inflammatory agent, from the adrenal cortex. Recent studies that support our hypothesis have demonstrated that electroacupuncture on LU-5 notably increases the level of dopamine in the hypothalamus \[[@B35]\], which can activate the HPA axis through dopaminergic neurons in the hypothalamus \[[@B5]\]. Nevertheless, because there is still a lack of research into the direct neurological relationship between the LU-5 acupoint and the PVN, the details of that neurological mechanism need to be investigated in further study.

In conclusion, the results of the current study demonstrate the anti-inflammatory effects of dBV treatment in a carrageenan-induced pleurisy model. The stimulation of the LU-5 acupoint with dBV significantly suppressed the accumulation of pleural exudate, the migration of leukocyte into the pleural cavity, the increase of MPO activity, and the production of IL-1β. These results indicate that dBV apipuncture at the LU-5 acupoint can be a novel alternative therapeutic strategy for respiratory inflammatory disease.
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![Graphs illustrating the effect of diluted bee venom (dBV) treatment on exudate volume in carrageenan (CA)-induced pleurisy. Intrapleural injection of CA significantly increased the exudate volume compared to that of sham animals (Sham). The 0.8 mg/kg dBV apipuncture of LU-5 (CA + BV-A 0.8) significantly blocked the increase of exudate volume compared to that of vehicle-treated CA mouse (CA + Veh) (*p* \< 0.05). However, 0.08 mg/kg dBV apipuncture of LU-5 (CA + BV-A 0.08) or 0.8 mg/kg dBV apipuncture of non-acupoint (CA + BV-NA 0.8) did not change the exudate volume compared to that of vehicle-treated CA mouse (CA + Veh). ^\*\*\*^*p* \< 0.001 compared to that of sham animals.](jvs-19-708-g001){#F1}

![Graphs illustrating the effect of diluted bee venom (dBV) treatment on leukocyte accumulation in pleural exudate. Intrapleural injection of carrageenan (CA) markedly induced the accumulation of leukocytes into the CA-injected pleural cavity compared to that of sham animals (Sham). The 0.8 mg/kg dBV apipuncture of LU-5 (CA + BV-A 0.8) significantly inhibited the accumulation of leukocytes in pleural exudate compared with that of vehicle-treated CA mouse (CA + Veh) (*p* \< 0.01). However, 0.08 mg/kg dBV apipuncture of LU-5 (CA + BV-A 0.08) or 0.8 mg/kg dBV apipuncture of non-acupoint (CA + BV-NA 0.8) did not affect the number of leukocytes in pleural exudate compared to that of vehicle-treated CA group (CA + Veh). ^\*\*\*^*p* \< 0.001 compared to that of sham animals.](jvs-19-708-g002){#F2}

![Graphs illustrating the effect of diluted bee venom (dBV) treatment on myeloperoxidase (MPO) activity in pleural exudate. Intrapleural injection of carrageenan (CA) significantly increased the MPO activity in pleural exudate compared to that of sham animals (Sham). The CA mouse treated with 0.8 mg/kg dBV apipuncture of LU-5 (CA + BV-A 0.8) had significantly reduced MPO activity as compared to that of vehicle-treated CA mouse (CA + Veh) (*p* \< 0.05). However, the CA mouse treated with 0.08 mg/kg dBV apipuncture of LU-5 (CA + BV-A 0.08) or 0.8 mg/kg dBV apipuncture of non-acupoint (CA + BV-NA 0.8) did not show significant changes in MPO activity compared to that of vehicle-treated CA mouse (CA + Veh). RFU, relative fluorescence units. ^\*\*\*^*p* \< 0.001 compared to that of sham animals.](jvs-19-708-g003){#F3}

![Graphs illustrating the effect of diluted bee venom (dBV) treatment on levels of proinflammatory cytokines in pleural exudate. Intrapleural injection of carrageenan (CA) significantly increased the production of interleukin 1 beta (IL-1β) (A) and tumor necrosis factor alpha (TNF-α) (B) in pleural exudate compared to that of sham animals (Sham). (A) 0.8 mg/kg dBV apipuncture of LU-5 (CA + BV-A 0.8) significantly inhibited the upregulation of IL-1β production compared to that of vehicle-treated CA mouse (CA + Veh) (*p* \< 0.05). However, 0.08 mg/kg dBV apipuncture of LU-5 (CA + BV-A 0.08) or 0.8 mg/kg dBV apipuncture of non-acupoint (CA + BV-NA 0.8) did not affect the level of IL-1β. (B) Treatment of dBV on neither the LU-5 acupoint nor a non-acupoint did not change the level of TNF-α compared to that of vehicle-treated CA mouse (CA + Veh). ^\*\*\*^*p* \< 0.001 compared to that of sham animals.](jvs-19-708-g004){#F4}

![Graphs and photomicrographs illustrating the effect of diluted bee venom (dBV) treatment on Fos expression in the ipsilateral (Ipsi) and contralateral (Contra) hypothalamic paraventricular nucleus (PVN). (A) Two hours after 0.8 mg/kg dBV stimulation of the LU-5 acupoint, the number of Fos-immunoreactive (Fos-ir) neurons significantly increased in the contralateral side of PVN in the dBV-treated group (BV-A 0.8) compared to that of the vehicle-treated group (Veh-A) (*p* \< 0.05). (B) Representative PVN sections demonstrating the typical pattern of Fos-ir in the groups. Scale bars = 100 µm.](jvs-19-708-g005){#F5}
